Used as a key chiral intermediate in the synthesis of certain fluorinated pharmaceutical agents, particularly in the development of protease inhibitors and antiviral drugs. Its bromo and fluoro substituents facilitate selective cross-coupling reactions, enabling precise structural modifications. The benzoyl group enhances stability during peptide coupling steps, making it valuable in multi-step organic syntheses where stereochemical control is critical. Commonly employed in research settings for designing bioactive molecules with improved metabolic resistance and target specificity.